RARα2 expression confers myeloma stem cell features-Reference-Cited by-同舟云学术

RARα2 expression confers myeloma stem cell features

Published:2013-08-22 Issue:8 Volume:122 Page:1437-1447
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Yang Ye¹,Shi Jumei²,Tolomelli Giulia³,Xu Hongwei¹,Xia Jiliang¹,Wang He¹,Zhou Wen¹,Zhou Yi¹,Das Satyabrata¹,Gu Zhimin¹,Levasseur Dana¹,Zhan Fenghuang¹,Tricot Guido¹

Affiliation:

1. Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA;

2. Department of Hematology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China; and

3. Department of Hematology and Oncology “L. e A. Seràgnoli,” St Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy

Abstract

Key Points RARα2 activates Wnt and hedgehog pathways in maintaining myeloma stem cell features and drug resistance.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/122/8/1437/1374335/1437.pdf

Reference44 articles.

1. Stem cells, cancer, and cancer stem cells.;Reya;Nature,2001

2. Cancer stem cells.;Jordan;N Engl J Med,2006

3. Characterization of clonogenic multiple myeloma cells.;Matsui;Blood,2004

4. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.;Bao;Nature,2006

5. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance.;Matsui;Cancer Res,2008

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between Th17 cell proportion and IL-17/-18 levels and disease progression in patients with multiple myeloma;Molecular & Cellular Toxicology;2023-12-12

2. Targeting cancer hallmark vulnerabilities in hematologic malignancies by interfering with Hedgehog/GLI signaling;Blood;2023-12-07

3. Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer;Molecular Cancer;2023-10-18

4. Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics;Frontiers in Cell and Developmental Biology;2023-05-25

5. Periplocin Overcomes Bortezomib Resistance by Suppressing the Growth and Down-Regulation of Cell Adhesion Molecules in Multiple Myeloma;Cancers;2023-02-28